Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;59(9):2974-2988.
doi: 10.1111/trf.15435. Epub 2019 Jul 3.

Pathogen reduced plasma products: a clinical practice scientific review from the AABB

Melissa M Cushing  1 , Monica B Pagano  2 , Jessica Jacobson  3 , Joseph Schwartz  4 , Brenda J Grossman  5 , Steven Kleinman  6 , Mi Ah Han  7 , Claudia S Cohn  8 ; AABB Clinical Transfusion Medicine Committee
Affiliations

Pathogen reduced plasma products: a clinical practice scientific review from the AABB

Melissa M Cushing et al. Transfusion. 2019 Sep.

Abstract

Background: A small body of literature assessing the efficacy and safety of pathogen reduced (PR) plasma has been published.

Study design and methods: An AABB committee systematically reviewed the literature and graded the clinical trial evidence with the assistance of a GRADE expert.

Results: Most studies identified were low quality and had a small sample size; in addition, efficacy and safety were monitored in many different ways making it difficult to quantify therapeutic benefit and risk. The data analyzed in this systematic review showed that pathogen inactivation did not adversely affect the efficacy of S/D or amotosalen plasma transfusions in any patient population studied. In addition, there were no significant safety issues for these patient populations, other than the specific contraindications noted in their respective package inserts.

Conclusion: Larger, well-designed trials are needed to further evaluate the efficacy and safety of all of the PR plasma products.

PubMed Disclaimer

References

REFERENCES

    1. Yang L, Stanworth S, Hopewell S, et al. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012;52:1673-86.
    1. Triulzi D, Gottschall J, Murphy E, et al. A multicenter study of plasma use in the United States. Transfusion 2015;55:1313-9.
    1. Holland L, Sarode R. Should plasma be transfused prophylactically before invasive procedures? Curr Opin Hematol 2006;13:447-51.
    1. Stanworth SJ, Hyde CJ, Murphy MF. Evidence for indications of fresh frozen plasma. Transfus Clin Biol 2007;14:551-6.
    1. Segal JB, Dzik WH, Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45:1413-25.

Publication types

MeSH terms